1363 / 1851
DFS
•
Defined as the time from randomization to
any event, (irrespective of cause)
•
is the most informative endpoint for assessing
the effect of treatment and therefore the
most relevant to clinical practice.
•
Accepted surrogate for OS in colon cancer
adjuvant trials
•
Not yet accepted in rectal cancer trials of CRT